Prognostic Implications of p27 and Cyclin E Protein Contents in Malignant Lymphomas
- 1 January 2001
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 40 (5-6) , 461-470
- https://doi.org/10.3109/10428190109097645
Abstract
The G1/S transition in the cell cycle is one of the checkpoints that can be deregulated in tumor development potentially causing increased proliferation and impaired capacity to arrest genetically damaged cells. The balance between activating and inhibitory molecules acting in the check point area seems to be critical and overexpression of cyclins and/or downregulation of the cdk inhibitors have been observed in many malignancies including lymphomas. In this review we have focused on two of the interplayers in the G1/S transition namely cyclin E and p27, and present the current knowledge of aberrations affecting these proteins in lymphomas as well as associations with clinico-pathological data including survival.Keywords
This publication has 42 references indexed in Scilit:
- Loss of p16/INK4A Protein Expression in Non-Hodgkin's Lymphomas Is a Frequent Finding Associated with Tumor ProgressionThe American Journal of Pathology, 1998
- Analysis of cyclin E and CDK2 in ovarian cancer: Gene amplification and RNA overexpressionInternational Journal of Cancer, 1998
- Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma proteinOncogene, 1997
- Aberrations of the G1- and G1/S-regulating genes in human cancerPublished by Springer Nature ,1997
- Cancer Cell CyclesScience, 1996
- Cell Cycle Checkpoints: Preventing an Identity CrisisScience, 1996
- Human Cyclin E, a Nuclear Protein Essential for the G1-to-S Phase TransitionMolecular and Cellular Biology, 1995
- Inhibition of cyclin-dependent kinases by p21.Molecular Biology of the Cell, 1995
- Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.Genes & Development, 1994
- Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasiaGenomics, 1992